134 related articles for article (PubMed ID: 27752882)
1. Gene expression, signal transduction pathways and functional networks associated with growth of sporadic vestibular schwannomas.
Sass HC; Borup R; Alanin M; Nielsen FC; Cayé-Thomasen P
J Neurooncol; 2017 Jan; 131(2):283-292. PubMed ID: 27752882
[TBL] [Abstract][Full Text] [Related]
2. Deregulated genes in sporadic vestibular schwannomas.
Cayé-Thomasen P; Borup R; Stangerup SE; Thomsen J; Nielsen FC
Otol Neurotol; 2010 Feb; 31(2):256-66. PubMed ID: 19816230
[TBL] [Abstract][Full Text] [Related]
3. Gene-expression profiling elucidates molecular signaling networks that can be therapeutically targeted in vestibular schwannoma.
Agnihotri S; Gugel I; Remke M; Bornemann A; Pantazis G; Mack SC; Shih D; Singh SK; Sabha N; Taylor MD; Tatagiba M; Zadeh G; Krischek B
J Neurosurg; 2014 Dec; 121(6):1434-45. PubMed ID: 25245477
[TBL] [Abstract][Full Text] [Related]
4. cDNA microarray analysis of vestibular schwannomas.
Welling DB; Lasak JM; Akhmametyeva E; Ghaheri B; Chang LS
Otol Neurotol; 2002 Sep; 23(5):736-48. PubMed ID: 12218628
[TBL] [Abstract][Full Text] [Related]
5. Retinoblastoma-cyclin-dependent kinase pathway deregulation in vestibular schwannomas.
Lasak JM; Welling DB; Akhmametyeva EM; Salloum M; Chang LS
Laryngoscope; 2002 Sep; 112(9):1555-61. PubMed ID: 12352662
[TBL] [Abstract][Full Text] [Related]
6. Microarray analysis of gene expression in vestibular schwannomas reveals SPP1/MET signaling pathway and androgen receptor deregulation.
Torres-Martin M; Lassaletta L; San-Roman-Montero J; De Campos JM; Isla A; Gavilan J; Melendez B; Pinto GR; Burbano RR; Castresana JS; Rey JA
Int J Oncol; 2013 Mar; 42(3):848-62. PubMed ID: 23354516
[TBL] [Abstract][Full Text] [Related]
7. Tumor miRNA expression profile is related to vestibular schwannoma growth rate.
Sass HCR; Hansen M; Borup R; Nielsen FC; Cayé-Thomasen P
Acta Neurochir (Wien); 2020 May; 162(5):1187-1195. PubMed ID: 32016588
[TBL] [Abstract][Full Text] [Related]
8. Contemporary Molecular Biology of Sporadic Vestibular Schwannomas: A Systematic Review and Clinical Implications.
Sass H; Cayé-Thomasen P
J Int Adv Otol; 2018 Aug; 14(2):322-329. PubMed ID: 30100540
[TBL] [Abstract][Full Text] [Related]
9. Global gene expression profiling and tissue microarray reveal novel candidate genes and down-regulation of the tumor suppressor gene CAV1 in sporadic vestibular schwannomas.
Aarhus M; Bruland O; Sætran HA; Mork SJ; Lund-Johansen M; Knappskog PM
Neurosurgery; 2010 Oct; 67(4):998-1019; discussion 1019. PubMed ID: 20881564
[TBL] [Abstract][Full Text] [Related]
10. Tumor-associated macrophages are related to volumetric growth of vestibular schwannomas.
de Vries M; Briaire-de Bruijn I; Malessy MJ; de Bruïne SF; van der Mey AG; Hogendoorn PC
Otol Neurotol; 2013 Feb; 34(2):347-52. PubMed ID: 23295727
[TBL] [Abstract][Full Text] [Related]
11. Molecular genetics alterations and tumor behavior of sporadic vestibular schwannoma from the People's Republic of China.
Bian LG; Tirakotai W; Sun QF; Zhao WG; Shen JK; Luo QZ
J Neurooncol; 2005 Jul; 73(3):253-60. PubMed ID: 15980976
[TBL] [Abstract][Full Text] [Related]
12. The molecular biology and novel treatments of vestibular schwannomas.
Fong B; Barkhoudarian G; Pezeshkian P; Parsa AT; Gopen Q; Yang I
J Neurosurg; 2011 Nov; 115(5):906-14. PubMed ID: 21800959
[TBL] [Abstract][Full Text] [Related]
13. Gene discovery using a human vestibular schwannoma cDNA library constructed from a patient with neurofibromatosis type 2 (NF2).
Halum SL; Erbe CB; Friedland DR; Wackym PA
Otolaryngol Head Neck Surg; 2003 Mar; 128(3):364-71. PubMed ID: 12646839
[TBL] [Abstract][Full Text] [Related]
14. Expression of vascular endothelial growth factor and basic fibroblast growth factor in sporadic vestibular schwannomas correlates to growth characteristics.
Koutsimpelas D; Stripf T; Heinrich UR; Mann WJ; Brieger J
Otol Neurotol; 2007 Dec; 28(8):1094-9. PubMed ID: 17721409
[TBL] [Abstract][Full Text] [Related]
15. Age dependent phosphorylation and deregulation of p53 in human vestibular schwannomas.
Dayalan AH; Jothi M; Keshava R; Thomas R; Gope ML; Doddaballapur SK; Somanna S; Praharaj SS; Ashwathnarayanarao CB; Gope R
Mol Carcinog; 2006 Jan; 45(1):38-46. PubMed ID: 16299809
[TBL] [Abstract][Full Text] [Related]
16. [Neurotrophic factor expression in vestibular schwannoma. An overview].
Diensthuber M; Lenarz T; Stöver T
Laryngorhinootologie; 2006 Oct; 85(10):731-7. PubMed ID: 16612755
[TBL] [Abstract][Full Text] [Related]
17. Erythropoietin and erythropoietin receptor expression in vestibular schwannoma: potential role in tumor progression.
Diensthuber M; Ilner T; Rodt T; Samii M; Brandis A; Lenarz T; Stöver T
Otol Neurotol; 2007 Jun; 28(4):559-65. PubMed ID: 17429338
[TBL] [Abstract][Full Text] [Related]
18. Gene expression profiles between cystic and solid vestibular schwannoma indicate susceptible molecules and pathways in the cystic formation of vestibular schwannoma.
Yan S; Wang Q; Huo Z; Yang T; Yin X; Wang Z; Zhang Z; Wu H
Funct Integr Genomics; 2019 Jul; 19(4):673-684. PubMed ID: 30953268
[TBL] [Abstract][Full Text] [Related]
19. Loss of heterozygosity on chromosome 22 in sporadic schwannoma and its relation to the proliferation of tumor cells.
Bian LG; Sun QF; Tirakotai W; Zhao WG; Shen JK; Luo QZ; Bertalanffy H
Chin Med J (Engl); 2005 Sep; 118(18):1517-24. PubMed ID: 16232328
[TBL] [Abstract][Full Text] [Related]
20. M-CSF and IL-34 expression as indicators for growth in sporadic vestibular schwannoma.
de Vries WM; Briaire-de Bruijn IH; van Benthem PPG; van der Mey AGL; Hogendoorn PCW
Virchows Arch; 2019 Mar; 474(3):375-381. PubMed ID: 30580386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
